Skip to main content
. Author manuscript; available in PMC: 2010 Jun 25.
Published in final edited form as: Epidemiology. 2009 May;20(3):400–410. doi: 10.1097/EDE.0b013e31819d90f9

TABLE 2.

Posterior Medians and 95% Credible Intervals for Variance Components and Relative Risk of COPD Mortality Associated With Cumulative Smoking Proxy Plus Measures of Model Fit

Parameter Model 1 Model 2 Model 3
(1) Total between-district variance in (log) risk
 COPD Varli) 0.065 (0.063–0.068) Varli) 0.065 (0.063–0.067) Varli) 0.065 (0.063–0.067)
 Lung cancer Var(logy2ie2i) 0.042 Var2i) 0.041 (0.039–0.043) Var2i) 0.041 (0.039–0.043)
(2) Overdispersion variance
 COPD σ12 0.0039 (0.001–0.007) σ12 0.0006 (0.0001–0.0023) σ12 0.0006 (0.0001–0.0026)
 Lung cancer σ22 0.0031 (0.0013–0.0049) σ22 0.0031 (0.0013–0.0049)
(3) Between-district
 variance
 of shared (log) risk
Var(βlogy2ie2i) 0.039 (0.034–0.045) Var(βϕi) 0.054 (0.046–0.063) Var(δϕi) 0.061 (0.047–0.069)
(4) Between-district variance of disease-specific residual (log) risk
 COPD Vari) 0.019 (0.016–0.023) Varli) 0.018 (0.015–0.021) Varli) 0.0060 (0.0002–0.022)
 Lung cancer 0 0 Var2i) 0.0065 (0.0002–0.013)
(5) Fraction of total spatial variation shared with other disease
 COPD Var(βlogy2ie2i)Var(βlogy2ie2i)+Var(ψ1i) 66.9% (61.1%–72.5%) Var(βϕi)Var(βϕi)+Var(ψ1i) 75.0% (70.0%-79.5%) Var(δϕi)Var(δϕi)+Var(ψ1i) 91.0% (71.4%–99.7%)
 Lung cancer 100% 100% Var(ϕiδ)Var(ϕiδ)+Var(ψ2i) 83.9% (70.8%–99.5%)
(6) RR of COPD mortality
 associated with unit
 increase in smoking
 proxya
exp(β) 2.62 (2.44–2.80) exp(β*) 3.33 (2.94–3.74) exp(δ2) 3.74 (3.05–4.41)
(7) Deviance 904.3 914.0 913.8
(8) DIC 1775.0 1694.2 1694.4
a

A difference of 1 unit in the value of the smoking proxy between 2 areas can be thought of as equivalent to a difference of 1 in the log relative risk of lung cancer in those 2 areas (see text for further explanation).